Sponsored Seminar

5/12 (Mon) 7:35-8:20 203

Morning Seminar 1 (MOCHIDA PHARMACEUTICAL CO.,LTD.)

Chair

Norihiko Takeda

• 
  Treatment strategies for residual risk factors for cardiovascular events

  Junichi Yamaguchi

5/12 (Mon) 12:30-13:15 A+B

Luncheon Seminar 1 (ONO PHARMACEUTICAL & AstraZenaca K.K.)

Chair

Issei Komuro

• 
  SGLT2 inhibitor and Heart Failure - insight into the mode of action -

  Yasushi Sakata

5/12 (Mon) 12:30-13:15 201+202

Luncheon Seminar 2 (GlaxoSmithKline K.K.)

Chair

Michihiro Yoshimura

• 
  Life-Style Related Disease and Prevention of Herpes Zoster

  Minako Tojo

5/12 (Mon) 12:30-13:15 203

Luncheon Seminar 3 (Novartis Pharma K.K. & Otsuka Pharmaceutical)
Road to ARNI past 5 years in Japan

Chair

Kazuhiro Yamamoto

• 
  Evidence of ARNI in Heart Failure: Up To Date

  Kotaro Nochioka
• 
  Hypertension management and healthy aging

  Koichi Yamamoto

5/12 (Mon) 12:30-13:15 204

Luncheon Seminar 4 (Mallinckrodt Pharmaceuticals)

Chair

Satoaki Matoba

• 
  Right Ventricular Function and Pulmonary Circulation:Insights from PV Loop and Circulatory Equilibrium

  Keita Saku
• 
  NO Hesitation ~ Inhaled Nitric Oxide in Advanced Heart Failure Management ~

  Takahiro Okumura

5/13 (Tue) 12:15-13:00 A+B

Luncheon Seminar 5 (Novo Nordisk Pharma Ltd.)
Comprehensive risk management for cardiovascular disease

Chair

Koichi Node

• 
  Treatment Strategies for Complications of Type 2 Diabetes with Consideration of Cardiovascular Diseases

  Tohru Minamimo
• 
  Weight Management Strategies Considering Cardiovascular Disease

  Motoaki Sano

5/13 (Tue) 12:15-13:00 201+202

Luncheon Seminar 6 (Bayer Yakuhin, Ltd.)

Chair

Issei Komuro

• 
  New perspective in the treatment of heart failure: HFpEF and WHF

  Koichiro Kuwahara

5/13 (Tue) 12:15-13:00 203

Luncheon Seminar 7 (DAIICHI SANKYO COMPANY, LIMITED)
Management of high bleeding risk atrial fibrillation patients-From Japan to the world-

Chair

Michihiro Yoshimura

• 
  Lessons from the ANAFIE Registry and ELDERCARE-AF trial

  Ken Okumura

5/13 (Tue) 12:15-13:00 204

Luncheon Seminar 8 (Eli Lilly Japan & Nippon Boehringer Ingelheim)

Chair

Masahiko Kurabayashi

• 
  Real-world Heart Failure Practice and Cardiorenal Interaction

  Takayuki Inomata

5/14 (Wed) 12:15-13:00 A+B

Luncheon Seminar 9 (Nippon Boehringer Ingelheim & Eli Lilly Japan)

Chair

Yoshihiko Saito

• 
  Heart Failure and Chronic Kidney Disease: Identifying High-Risk Individuals and Strategies for Management

  Yuya Matsue

5/14 (Wed) 12:15-13:00 201+202

Luncheon Seminar 10 (Novartis Pharma K.K.)

Chair

Satoaki Matoba

• 
  Paradigm Shift in Lipid-Lowering Therapy for ASCVD: Insights from Clinical Applications of Inclisiran

  Yoshiyasu Minami

5/14 (Wed) 12:15-13:00 203

Luncheon Seminar 11 (Bristol-Myers Squibb)

Chair

Yasushi Sakata

• 
  Current status of Hypertrophic obstructive cardiomyopathy

  Shungo Hikoso